Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

24/04/2025 09:00

Apr 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              288.46              236.95                     
                   (+21.7 pct)         (-24.1 pct)                  
  Operating          136.65               99.87                     
                   (+36.8 pct)         (+1.6 pct)                   
  Pretax
  Net                 97.23               74.40                     
                   (+30.7 pct)         (+1.2 pct)                   
  EPS Basic         59.09 yen           45.22 yen                   
  EPS Diluted       59.08 yen           45.21 yen                   
  Ann Div                               98.00 yen       250.00 yen  
  -Q2 Div                               41.00 yen       125.00 yen  
  -Q4 Div                               57.00 yen       125.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T